Infectious events in patients with severe COVID-19: results of a cohort of patients with high prevalence of underlying immune defect.

Anastasia SaadeGiulia MoratelliGuillaume DumasAsma MabroukiJean-Jacques TudesqLara ZafraniElie AzoulayMichaël Darmon

Published in: Annals of intensive care (2021)

In this population of COVID-19 patients with high prevalence of underlying immune defect, a high risk of infections was noted. MV and use of steroids were independently associated with infection rate.

Keyphrases

sars cov
coronavirus disease
early onset
drug induced